The program, launched in 2014 and established with generous support from The Rose Hills Foundation, supports distinguished early-career faculty in the STEM fields.
A new study co-authored by MCB, Chemistry & NST Associate Professor Dan Nomura investigates how nimbolide, a natural product derived from the neem tree, may function in impairing cancer pathogenicity.
“We discover here that nimbolide not only impairs cancer pathogenicity through stabilizing tumor suppressors, but that we can exploit nimbolide to also degrade and eliminate other cancer-causing proteins in cells for cancer therapy,” said Nomura.
The pharmaceutical company GlaxoSmithKline (GSK) has announced a five-year collaboration with UC Berkeley and UCSF to establish the Laboratory for Genomics Research (LGR), where state-of-the-art CRISPR techniques will be used to advance the genomic research and rapidly accelerate new drug development.
“LGR is about building that space where creative science is partnered with the development of robust technology that will help develop tomorrow’s drugs. I think we’re going to be able to do science that none of us can even imagine today," said MCB & Chemistry Professor Jennifer Doudna, who will be a member of the LGR's steering committee.
Congratulations to MCB Graduate Student Financial Specialist Eric Buhlis, recipient of a Staff Achievement Award from the UC Berkeley College of Letters & Science!
Eric was recognized for setting the gold standard for helping graduate students navigate their often-complicated funding information, thus enabling those students to better plan financially. He is an exemplary employee and team player whose dedication to MCB deserves the highest praise.